Conversely, CCR5 targeting could offer therapeutic advantages in some autoimmune diseases, as rheumatoid arthritis [78], or in transplantation therapy, all situations where chemokine signaling and cell recruitment might sustain tissue damage [79]. Here, CCR5 is linked to autoimmune disease.